Stewart Jonathan W, Quitkin Frederic M, McGrath Patrick J, Klein Donald F
New York State Psychiatric Institute, United States; Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, NY, USA.
J Affect Disord. 2005 Jun;86(2-3):161-7. doi: 10.1016/j.jad.2005.01.009.
Treatment outcome and brain laterality differ between early onset (<20 years) chronically (no well-being >2 months) depressed patients with atypical features (early/chronic atypical) and those with either later onset or less chronic illness (late/nonchronic atypical). Because hypothalamic-pituitary-adrenal (HPA) axis abnormalities have been hypothesized to distinguish atypical depression from melancholia, we examined whether HPA measures would also differentiate these two groups of depressed patients with atypical features.
Three-hour afternoon cortisol levels, stimulation of cortisol by afternoon dextroamphetamine, and suppression of cortisol by dexamethasone were investigated in 85 depressed patients with atypical features. The latter group was divided into early/chronic atypical and late/nonchronic atypical based on chart review of course of illness.
Patients with early/chronic atypical had significantly lower mean 3 h afternoon cortisol levels (N=21) and 4:00 p.m. post-dexamethasone cortisol levels (N=20) than did those with late/nonchronic atypical (N=43 with afternoon cortisol; N=26 with post-dexamethasone cortisol). Post-dextroamphetamine cortisol levels were numerically higher in the early/chronic atypical group (N=15 vs. 19), but this failed to reach conventional significance (0.05<p<0.1). Arbitrary categorical distinctions of normal and abnormal did not separate these groups on any of the tests.
Lack of demonstrated reliability of the chart review and retrospective determination of atypical features and course of illness limit the generalizability of these findings.
These HPA data are consistent with earlier treatment and brain laterality findings that course of illness distinguishes biologically distinct groups within depressed patients with atypical features. The DSM should consider adding course of illness requirements to its criteria for atypical features.
早发性(<20岁)慢性(幸福感缺失>2个月)且具有非典型特征的抑郁症患者(早发性/慢性非典型)与晚发性或非慢性疾病患者(晚发性/非慢性非典型)在治疗结果和脑半球优势方面存在差异。由于下丘脑-垂体-肾上腺(HPA)轴异常被认为是区分非典型抑郁症和忧郁症的依据,我们研究了HPA指标是否也能区分这两组具有非典型特征的抑郁症患者。
对85例具有非典型特征的抑郁症患者进行了下午3小时皮质醇水平、下午右旋苯丙胺刺激皮质醇以及地塞米松抑制皮质醇的研究。根据疾病病程的图表回顾,将后一组患者分为早发性/慢性非典型和晚发性/非慢性非典型。
早发性/慢性非典型患者的平均下午3小时皮质醇水平(N = 21)和地塞米松后下午4点皮质醇水平(N = 20)显著低于晚发性/非慢性非典型患者(下午皮质醇水平N = 43;地塞米松后皮质醇水平N = 26)。早发性/慢性非典型组的右旋苯丙胺后皮质醇水平在数值上更高(N = 15对19),但未达到传统意义上的显著性(0.05 < p < 0.1)。在任何一项测试中,正常和异常的任意分类区分都未能将这些组分开。
图表回顾缺乏已证明的可靠性以及非典型特征和疾病病程的回顾性确定限制了这些发现的普遍性。
这些HPA数据与早期治疗和脑半球优势的研究结果一致,即疾病病程区分了具有非典型特征的抑郁症患者中生物学上不同的组。《精神疾病诊断与统计手册》应考虑在其非典型特征标准中增加疾病病程要求。